Thank you to our Foundational and Sustaining members
MINNEAPOLIS, July 17, 2019 /PRNewswire/ ‐‐ Bio‐Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8‐Plex cartridge format for the ProteinSimple™‐branded Ella™ automated immunoassay platform. This new cartridge format analyzes 32 samples for eight distinct analytes, bringing higher multiplex capabilities to the Ella platform. The 32×8 cartridge for Ella enables users to build […]
Boston Scientific plans for 75 new products by 2022 Top US hospital opens London clinic offering £5k ‘health MoTs’ Reprise Biomedical Raises $12.5 Million and Completes Spin-Off From Miromatrix Medical UnitedHealth Group Invests In Job Of The Future: ‘Data Scientists’ 6 MAA Members Make Forbes’ List of Best Employers for Women Joan Gabel takes helm […]
Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay. MINNEAPOLIS, July 11, 2019 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics™-branded RNAscope platform with release of the RNAscope HiPlex Assay. The RNAscope platform is an advanced in situ hybridization assay that […]
MINNEAPOLIS, July 9, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that its President and CEO, Chuck Kummeth, was recently honored with the EY Entrepreneur Of The Year® 2019 Award in the Heartland. The EY awards program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance, and […]
Minneapolis, June 26, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the “Decade of Contribution Award” at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne’s team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology industry. The 2019 (10th) […]
MINNEAPOLIS, June 25, 2019/PRNewswire/ — Bio-Techne Corporation today announced the appointment of Dr. Rupert Vessey to the company’s Board of Directors as an independent director. Dr. Vessey’s appointment brings the total number of Bio-Techne Board members to nine. Rupert Vessey, MA, BM BCh, FRCP, DPhil is currently the President of Global Research and Early Development […]
MINNEAPOLIS, June 17, 2019 /PRNewswire/ — Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not only validates the clinical importance of Bio-Techne’s EPI test, […]
The EPI prostate biopsy rule-out test is now available in every state MINNEAPOLIS, June 13, 2019 /PRNewswire/ — Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its ExoDx Prostate IntelliScore (EPI) test in New York, providing a valuable tool to help Urologists […]
Smiths Medical Appoints New CEO Medical device makers in Minnesota, U.S. brace for tariff fallout Mayo Clinic plans research building with $32 million gift Bio-Techne To Acquire B-MoGen Biotechnologies Inc. CVRx Adds $18m to Funding Round Upsizing Upsher-Smith Labs Medtronic wins $150m radiology, imaging equipment DoD supply contract Medical-data firm Flywheel nabs another $2.5 million […]
Minneapolis/June 4, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc. The transaction has been completed and is being financed through available cash on hand. “We are very pleased to include the B-MoGen technology in Bio-Techne’s expanding portfolio of products that serve […]